EAHAD 2025: Elevating Levels of Endogenous Circulating von Willebrand Factor (VWF): The Potential of HMB-002 as a Prophylactic Treatment of Von Willebrand Disease (VWD)

February 4, 2025
July 22, 2025

Presented at 18th Annual Congress of the European Association of Haemophilia and Allied Disorders

To view the presentation, click here